Pricing Log in Create free account
Saturday 17 October 2026 Export ISRG’s income statement to Excel — free account

Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Intuitive Surgical, Inc. (ISRG) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/EBITDA of 34.3×. Over the past ten years it has ranged from 18.6× (October 2015) to 74.8× (November 2024); the current reading is higher than 29% of that period. That is above the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 54.2× (14.94%)
FY2024 63.7× 27.42%
FY2023 50.0× 8.91%
FY2022 45.9× (19.77%)
FY2021 57.2× (15.25%)
FY2020 67.5× 65.14%
FY2019 40.9× 5.98%
FY2018 38.6× 13.19%
FY2017 34.1× 62.68%
FY2016 20.9× (4.17%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 31.9× (20.70%)
Mar 2026 40.2× (25.78%)
Dec 2025 54.2× 20.36%
Sep 2025 45.0× (24.45%)
42 more quarters

Against its own ten years

Low 18.6× High 74.8×
Ten-year median 41.8×
Current reading's percentile 29

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.1×
SOLV Solventum Corporation compare 7.6×
ALC Alcon compare 13.0×
BDX Becton, Dickinson and Company compare 13.7×
BAX Baxter International Inc. compare 14.0×
RMD ResMed Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 31.2×
ISRG Intuitive Surgical, Inc. 34.3×
RGEN Repligen Corporation compare 60.2×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ISRG